Your browser doesn't support javascript.
loading
Comparing health gains, costs and cost-effectiveness of 100s of interventions in Australia and New Zealand: an online interactive league table.
Carvalho, Natalie; Sousa, Tanara Vieira; Mizdrak, Anja; Jones, Amanda; Wilson, Nick; Blakely, Tony.
Afiliação
  • Carvalho N; Health Economics Unit, Centre for Health Policy, School of Population and Global Health, The University of Melbourne, Level 4, 207 Bouverie St, Parkville, VIC, 3010, Australia. natalie.carvalho@unimelb.edu.au.
  • Sousa TV; Music Therapy, Faculty of Fine Arts and Music, The University of Melbourne, Melbourne, Australia.
  • Mizdrak A; Burden of Disease Epidemiology, Equity, and Cost-Effectiveness Programme (BODE3), Department of Public Health, University of Otago, Wellington, New Zealand.
  • Jones A; Burden of Disease Epidemiology, Equity, and Cost-Effectiveness Programme (BODE3), Department of Public Health, University of Otago, Wellington, New Zealand.
  • Wilson N; Burden of Disease Epidemiology, Equity, and Cost-Effectiveness Programme (BODE3), Department of Public Health, University of Otago, Wellington, New Zealand.
  • Blakely T; Population Interventions Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Popul Health Metr ; 20(1): 17, 2022 07 27.
Article em En | MEDLINE | ID: mdl-35897104
BACKGROUND: This study compares the health gains, costs, and cost-effectiveness of hundreds of Australian and New Zealand (NZ) health interventions conducted with comparable methods in an online interactive league table designed to inform policy. METHODS: A literature review was conducted to identify peer-reviewed evaluations (2010 to 2018) arising from the Australia Cost-Effectiveness research and NZ Burden of Disease Epidemiology, Equity and Cost-Effectiveness Programmes, or using similar methodology, with: health gains quantified as health-adjusted life years (HALYs); net health system costs and/or incremental cost-effectiveness ratio; time horizon of at least 10 years; and 3% to 5% discount rates. RESULTS: We identified 384 evaluations that met the inclusion criteria, covering 14 intervention domains: alcohol; cancer; cannabis; communicable disease; cardiovascular disease; diabetes; diet; injury; mental illness; other non-communicable diseases; overweight and obesity; physical inactivity; salt; and tobacco. There were large variations in health gain across evaluations: 33.9% gained less than 0.1 HALYs per 1000 people in the total population over the remainder of their lifespan, through to 13.0% gaining > 10 HALYs per 1000 people. Over a third (38.8%) of evaluations were cost-saving. CONCLUSIONS: League tables of comparably conducted evaluations illustrate the large health gain (and cost) variations per capita between interventions, in addition to cost-effectiveness. Further work can test the utility of this league table with policy-makers and researchers.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Custos de Cuidados de Saúde Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans País como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Custos de Cuidados de Saúde Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans País como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article